4-Iodo-3-nitrobenzamide
CAS: 160003-66-7
Ref. 3D-FI140420
| 1g | To inquire | ||
| 2g | To inquire | ||
| 5g | To inquire | ||
| 10g | To inquire | ||
| 500mg | To inquire |
Product Information
- AntiPARP-2
- Benzamide, 4-iodo-3-nitro-
- Bsi 201
- Iniparib
- Ino2Ba
- Niba
- Sar240550
- Sml 0623
Iniparib is a cancer drug that belongs to the class of platinum-based chemotherapy drugs. It inhibits the activity of pro-apoptotic proteins and is used to treat ovarian cancer with low potency. Iniparib has been shown to inhibit the growth of breast cancer cells, as well as other types of cancers. The drug also has an inhibiting effect on metabolic disorders, such as obesity and diabetes, which may be linked to its homologous properties. Iniparib may be useful in treating certain cancers because it has minimal toxicity levels and a low potential for systemic side effects that are common with other chemotherapeutic agents.END>
Chemical properties
Technical inquiry about: 3D-FI140420 4-Iodo-3-nitrobenzamide
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
